03:42 AM EDT, 04/23/2026 (MT Newswires) -- Eric Venker, President &Immunovant Chief Executive Officer, on April 20, 2026, sold 200,000 shares in Roivant Sciences (ROIV) for $5,918,000. Following the Form 4 filing with the SEC, Venker has control over a total of 1,647,546 common shares of the company, with 1,647,546 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1635088/000163508826000044/xslF345X05/wk-form4_1776896865.xml

Ämnen i artikeln

Roivant Sciences

Senast

27,41

1 dag %

−2,59%

1 dag

1 mån

1 år

Marknadsöversikt

1 DAG %

Senast

1 mån